The serotonin transporter gene polymorphism STin2 VNTR confers an increased risk of inconsistent response to triptans in migraine patients-Reference-Cited by-同舟云学术

The serotonin transporter gene polymorphism STin2 VNTR confers an increased risk of inconsistent response to triptans in migraine patients

Published:2010-09 Issue:2-3 Volume:641 Page:82-87
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Terrazzino Salvatore,Viana Michele,Floriddia Elisa,Monaco Francesco,Mittino Daniela,Sances Grazia,Tassorelli Cristina,Nappi Giuseppe,Rinaldi Maurizio,Canonico Pier Luigi,Genazzani Armando A.

Publisher

Elsevier BV

Subject

Pharmacology

Reference30 articles.

1. Association study between clinical response to rizatriptan and some candidate genes;Asuni;J. Headache Pain,2007

2. Pathways to the best fit of triptans for migraine patients;Buzzi;Cephalalgia,2008

3. Advances in pharmacological treatment of migraine;Diener;Expert Opin. Investig. Drugs,2001

4. Triptan nonresponder studies: implications for clinical practice;Dodick;Headache,2005

5. Review of clinical trials using early acute intervention with oral triptans for migraine management;Dowson;Int. J. Clin. Pract.,2006

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are we closer to achieving precision medicine for migraine treatment? A narrative review;Cephalalgia;2024-09

2. The impact of genetic factors on the response to migraine therapy;Reviews in the Neurosciences;2024-06-11

3. New management strategies for primary headache disorders: Insights from P4 medicine;Heliyon;2023-11

4. Cluster headache polygenetic risk and known functional variants of CYP3A4 are not associated with treatment response;European Journal of Neurology;2023-03-02

5. Polymorphisms of the Proinflammatory Cytokine Genes Modulate the Response to NSAIDs but Not to Triptans in Migraine Attacks;International Journal of Molecular Sciences;2022-12-30